| Literature DB >> 32250346 |
Thomas Buchheit1,2, Yul Huh1,3, William Maixner1, Jianguo Cheng4, Ru-Rong Ji1,3,5.
Abstract
Regenerative pain medicine, which seeks to harness the body's own reparative capacity, is rapidly emerging as a field within pain medicine and orthopedics. It is increasingly appreciated that common analgesic mechanisms for these treatments depend on neuroimmune modulation. In this Review, we discuss recent progress in mechanistic understanding of nociceptive sensitization in chronic pain with a focus on neuroimmune modulation. We also examine the spectrum of regenerative outcomes, including preclinical and clinical outcomes. We further distinguish the analgesic mechanisms of regenerative therapies from those of cellular replacement, creating a conceptual and mechanistic framework to evaluate future research on regenerative medicine.Entities:
Mesh:
Year: 2020 PMID: 32250346 PMCID: PMC7190995 DOI: 10.1172/JCI134439
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808